Analytik Jena with Good Results in the First Half of the Financial Year 2011/2012
(Thomson Reuters ONE) -
Analytik Jena AG /
Analytik Jena with Good Results in the First Half of the Financial Year
2011/2012
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
* Revenue growth in the second quarter offsets weaker first quarter
* Growth in Asia well into double digits at 23.4 %
* Earnings with double-digit growth rates
Jena, May 10, 2012 - After six months of the current financial year, Analytik
Jena AG (Prime Standard: AJA, ISIN: DE0005213508) has recorded very good
development of its operating business. The instrument manufacturer for
analytical measuring technology and life science generated consolidated revenue
of EUR 46.0 m (previous year: EUR 44.5 m). With growth rates of 26.3 % in
operating profit (EBIT), 156.2 % in earnings before tax, 156.3 % in consolidated
net profit for the period and 161.5 % in earnings per share, the Company
considerably improved its earnings situation after six months compared with the
previous year.
"We succeeded in compensating for the somewhat weaker start to the new financial
year and have achieved significant progress year-on-year on the revenue and
income side. We have thus created a good base from which we can realize our
goals for the financial year as a whole," said Klaus Berka, CEO of Analytik Jena
AG.
Revenue Development and Segments
After the first quarter of the current financial year remained below the
previous year, operational business benefited from very good business in the
second quarter. As a result, Analytik Jena was able to achieve growth totaling
3.5 % after six months.
Revenue in the Asia region, by far the most important region for the Company,
rose considerably once again. In this region, a double-digit gain of 23.4 % was
generated after six months, with revenue of EUR 17.5 m (previous year: EUR 14.2
m). For the first time, business in Asia benefited particularly from the
development in Japan. In the course of the second quarter, Analytik Jena's
business development accelerated markedly in this market, following the
portfolio expansion with x-ray fluorescence devices as part of a distribution
partnership with the Japanese company Techno-X.
After the first six months of the current financial year, Analytik Jena also
draws an overall positive conclusion in respect to revenue of the three
segments. Revenue in the core business Analytical Instrumentation was 6.3 %
higher year-on-year at EUR 29.5 m (previous year: EUR 27.7 m). The Life Science
business unit achieved revenue of EUR 13.9 m (previous year: EUR 14.3 m) and was
down on the previous year's figures by 2.9 %. This is mainly due to slightly
declining revenue at CyBio AG, which is consolidated in this unit. In the
smallest business unit, Optics, Analytik Jena generated revenue of EUR 2.6 m
(previous year: EUR 2.4 m) in the reporting period, exceeding the previous-year
figure by 9.4 %.
Result
Analytik Jena increased its results significantly in the reporting period. The
Group generated earnings before interest, taxes, depreciation and amortization
(EBITDA) of EUR 5.3 m (previous year: EUR 4.5 m), up 18.7 % on the previous
year. Operating profit (EBIT) also was up by 26.3 % and amounted to EUR 3.3 m
(previous year: EUR 2.6 m) with an EBIT margin of 7.2 % (previous year: 5.9 %).
Earnings before tax (EBT) of EUR 2.9 m (previous year: EUR 1.1 m), which more
than doubled year-on-year, benefited especially from a positive result from the
investment of the 49 % minority interest investment AJZ Engineering and from
favorable foreign exchange rate movements in the financial year so far. Overall,
the Group posted net profit for the period of EUR 2.0 m (previous year: EUR 0.8
m), which corresponds to an increase of 156.3 %. The share of this attributable
to the shareholders of Analytik Jena AG totals EUR 1.8 m (previous year: EUR
0.7 m), which corresponds to earnings per share of EUR 0.34 (previous year: EUR
0.13).
Changes in Statement of Financial Position
The Group's total assets as of the balance sheet date on March 31, 2012
increased from EUR 83.6 m to EUR 89.1 m. In the reporting period, Analytik Jena
showed equity of EUR 45.3 m (as of September 30, 2011: EUR 38.6 m). This
corresponds to an increase of 17.5 %, which, in addition to the results
contribution, mainly results from the capital increase carried out at the
beginning of 2012. The equity ratio rose from 46.1 % as of September 30, 2011 to
50.8 % as of March 31, 2012. On the assets side, cash and cash equivalents
increased in the same context by 73.3 % in comparison with the end of the
2010/2011 financial year and amounted to EUR 9.5 m as of the balance sheet date
(as of September 30, 2011: EUR 5.5 m). The capital increase of EUR 4.9 m carried
out at the beginning of February, which together with external financing was
intended in particular for retroactive tax payments, the offer to CyBio AG
shareholders in connection with the planned delisting and a strategic expansion
of the portfolio, the realization of which failed in retrospect directly before
the contract was signed, stabilized the Company's liquidity position and
improved the equity base. In the reporting period, Analytik Jena recorded
operating cashflow of EUR 1.5 m.
Human Resources
As of the balance sheet date of March 31, 2012, the Group employed 813 staff,
including 37 trainees (previous year: 800 employees, including 39 trainees).
Outlook
Based on the good first half of 2011/2012, Analytik Jena expects the positive
development of its business to continue over the year as a whole. The Company
anticipates that all three segments will contribute to revenue and earnings
growth. In line with its forecast for the year, Analytik Jena AG estimates the
expected consolidated revenue for the financial year 2011/2012 at between EUR
91.0 m and EUR 93.0 m as well as expected operating profit at more than EUR 6.0
m.
Further Information
The full financial report is available at http://berichte.analytik-jena.de/6-
MonthReport_1112.pdf.
Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena, Germany
Tel. +49 3641 779281
Email: ir(at)analytik-jena.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Analytik Jena AG via Thomson Reuters ONE
[HUG#1610640]
Unternehmensinformation / Kurzprofil:
Datum: 10.05.2012 - 07:45 Uhr
Sprache: Deutsch
News-ID 144826
Anzahl Zeichen: 7432
contact information:
Town:
Jena
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Analytik Jena with Good Results in the First Half of the Financial Year 2011/2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Analytik Jena AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
